Leadership Overview
Amgen has 10 executives leading key functions including finance, information technology, project management, and oncology strategy.
Driven by scientific discovery, Amgen is dedicated to advancing human health through innovative biotechnology, impacting patient lives globally with groundbreaking therapies.
Driven by scientific discovery, Amgen is dedicated to advancing human health through innovative biotechnology, impacting patient lives globally with groundbreaking therapies.
Leadership Roles at Amgen
Carlos Mauricio - Chief Financial Officer
Carlos Mauricio, the Chief Financial Officer at Amgen, directs financial operations and fiscal strategy. Mauricio oversees budgeting, financial planning, and resource allocation, ensuring robust financial health across the organization. This leadership role involves managing Amgen's financial performance and reporting to stakeholders. By optimizing financial processes, Carlos Mauricio directly supports Amgen's mission to deliver innovative medicines. The focus remains on driving sustainable growth and maximizing shareholder value through sound financial management. Mauricio's oversight extends to financial risk assessment and mitigation strategies, safeguarding the company's assets and ensuring compliance with all financial regulations. This critical function underpins Amgen's ability to invest in research and development, ultimately advancing patient care.
Konosuke Sasaki - Head Chief Financial Officer, Country of Alliance & Director, Bd, Board of Amgen (Japan)
Konosuke Sasaki, the Head Chief Financial Officer, Country of Alliance & Director, Bd, Board of Amgen (Japan) at Amgen, manages financial operations and strategic alliances within the Japanese market. Sasaki oversees financial planning, reporting, and fiscal compliance specific to Amgen's Japanese operations and partnerships. This directorship involves guiding financial strategy to support regional growth and collaboration. By ensuring fiscal integrity, Konosuke Sasaki strengthens Amgen's presence and impact in Japan. The objective is to foster robust financial frameworks that enable successful market penetration and strategic partnerships. Sasaki's role is crucial for aligning financial objectives with Amgen's global mission within the unique context of the Japanese biotechnology landscape.
Marianela Capelli - Chief Financial Officer (Argentina)
Marianela Capelli, the Chief Financial Officer (Argentina) at Amgen, leads financial management and fiscal strategy within the Argentinian market. Capelli oversees all financial operations, including budgeting, forecasting, and financial reporting, ensuring compliance with local regulations. This role is critical for supporting Amgen's growth and operational objectives in Argentina. By maintaining rigorous financial oversight, Marianela Capelli contributes to the stability and success of Amgen's operations in the region. The focus is on implementing sound financial practices that align with Amgen's global financial standards while addressing specific market needs. Capelli's expertise ensures that financial resources are effectively managed to advance Amgen's mission of improving patient lives.
Carlos Collado - Chief Financial Officer, Country & LATAM Distributors (Mexico)
Carlos Collado, the Chief Financial Officer, Country & LATAM Distributors (Mexico) at Amgen, directs financial strategy and operations for Mexico and the broader LATAM distributor network. Collado manages financial planning, analysis, and reporting, ensuring fiscal health and compliance across these key regions. This leadership position involves optimizing financial performance and supporting strategic growth initiatives for Amgen's distributor partnerships. By providing robust financial oversight, Carlos Collado strengthens Amgen's market position and operational capabilities throughout Latin America. The focus is on driving financial efficiency and supporting the effective distribution of Amgen's innovative therapies. Collado's financial acumen is essential for navigating complex market dynamics and achieving Amgen's mission in the region.
Peter Griffith - Executive Vice President & Chief Financial Officer, Finance
Peter Griffith, the Executive Vice President & Chief Financial Officer, Finance at Amgen, oversees the company's comprehensive financial strategy and operations. Griffith directs all aspects of Amgen's financial planning, accounting, treasury, and investor relations functions. This executive leadership role is pivotal in guiding Amgen's financial health, resource allocation, and long-term fiscal sustainability. By ensuring robust financial management, Peter Griffith supports Amgen's ability to invest in groundbreaking research and development, driving innovation in biotechnology. The focus is on maximizing financial performance, managing risk effectively, and communicating financial strategy to stakeholders. Griffith's leadership is instrumental in maintaining Amgen's position as a leader in the biopharmaceutical industry and advancing its mission to serve patients.
Scott Skellenger - Senior Vice President and Chief Information Officer
Scott Skellenger, the Senior Vice President and Chief Information Officer at Amgen, architects the company's technology infrastructure and digital strategy. Skellenger directs the implementation of advanced IT solutions that support Amgen's global operations and research initiatives. This leadership position involves overseeing cybersecurity, data management, and the development of scalable technology platforms. By ensuring seamless technological integration, Scott Skellenger enhances operational efficiency and accelerates scientific discovery. The focus is on leveraging cutting-edge technology to drive innovation and maintain Amgen's competitive edge in the biotechnology sector. Skellenger's strategic vision guides the digital transformation efforts, enabling Amgen to better serve patients and healthcare providers worldwide through robust and secure information systems.
Stoyan Mihnev - Project Manager & Chief of Staff
Stoyan Mihnev, the Project Manager & Chief of Staff at Amgen, drives strategic initiatives and operational efficiency across key projects. Mihnev coordinates cross-functional teams, ensuring project timelines and objectives align with Amgen's broader corporate goals. This dual role involves managing complex projects while providing high-level support to executive leadership. By streamlining project execution, Stoyan Mihnev enhances Amgen's capacity for innovation and timely delivery of critical programs. The focus is on optimizing resource allocation and mitigating project risks to ensure successful outcomes. Mihnev's contributions are vital for advancing Amgen's pipeline and operational excellence, supporting the company's commitment to improving patient lives through scientific advancement.
Patrick Hylton - Chief of Staff, Oncology (US)
Patrick Hylton, the Chief of Staff, Oncology (US) at Amgen, spearheads strategic operations within the U.S. oncology division. Hylton directs initiatives aimed at enhancing Amgen's oncology portfolio's market presence and clinical impact. This leadership role involves close collaboration with R&D, commercial teams, and regulatory affairs to advance cancer therapies. By ensuring strategic alignment, Patrick Hylton accelerates the development and delivery of life-saving treatments to patients across the United States. The objective is to optimize the oncology business unit's performance and drive significant growth in this critical therapeutic area. Hylton's focus on operational excellence supports Amgen's mission to combat cancer through groundbreaking science.
Adrian Sparrow - Global Corporate Affairs Chief of Staff
Adrian Sparrow, the Global Corporate Affairs Chief of Staff at Amgen, directs strategic communications and stakeholder engagement initiatives worldwide. Sparrow oversees the coordination of corporate affairs functions, ensuring consistent messaging and effective outreach across diverse global markets. This role involves managing key relationships with external partners and internal stakeholders to advance Amgen's reputation and public policy objectives. By enhancing global communication strategies, Adrian Sparrow strengthens Amgen's brand presence and its commitment to patient advocacy. The focus is on building trust and fostering positive relationships that support the company's mission to improve health outcomes. Sparrow's leadership ensures that Amgen's corporate narrative effectively communicates its scientific achievements and societal contributions.
Katherine Rizos - Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer
Katherine Rizos, the Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer at Amgen, drives operational excellence and strategic planning across technology initiatives. Rizos supports the Chief Information Officer by managing critical projects and ensuring alignment between business objectives and IT operations. This position involves developing and implementing strategic plans that enhance efficiency and innovation within Amgen's technology landscape. By optimizing operational frameworks, Katherine Rizos facilitates the seamless integration of new technologies and supports Amgen's research and development efforts. The focus is on driving strategic execution and ensuring that IT operations effectively support the company's overarching mission to advance human health through biotechnology.
Explore Leadership Teams in Manufacturing
Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership GL
JR
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership CK
GO
Founded in 1993 and located in Cambridge, Massachusetts, Takeda Oncology is the oncology specialty business unit of Takeda Pharmaceutical. Takeda Oncology develops and produces oncology therapies for patients around the world.
Company Leadership
TF
CB
ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The Companys range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates natural killer cells, T cells, and memory T cells for a long-duration response. The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
Company Leadership FJ
Frequently Asked Questions Regarding Amgen Top Executives and Leadership Team
Unlock more people and company data
